BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9781544)

  • 1. Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.
    van den Bent MJ; Kros JM; Heimans JJ; Pronk LC; van Groeningen CJ; Krouwer HG; Taphoorn MJ; Zonnenberg BA; Tijssen CC; Twijnstra A; Punt CJ; Boogerd W
    Neurology; 1998 Oct; 51(4):1140-5. PubMed ID: 9781544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
    van den Bent MJ; Chinot O; Boogerd W; Bravo Marques J; Taphoorn MJ; Kros JM; van der Rijt CC; Vecht CJ; De Beule N; Baron B
    Ann Oncol; 2003 Apr; 14(4):599-602. PubMed ID: 12649108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
    Webre C; Shonka N; Smith L; Liu D; De Groot J
    Anticancer Res; 2015 Oct; 35(10):5467-72. PubMed ID: 26408710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
    Cairncross G; Macdonald D; Ludwin S; Lee D; Cascino T; Buckner J; Fulton D; Dropcho E; Stewart D; Schold C
    J Clin Oncol; 1994 Oct; 12(10):2013-21. PubMed ID: 7931469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.
    Streffer J; Schabet M; Bamberg M; Grote EH; Meyermann R; Voigt K; Dichgans J; Weller M
    J Neurol; 2000 Apr; 247(4):297-302. PubMed ID: 10836623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma.
    Paleologos NA; Macdonald DR; Vick NA; Cairncross JG
    Neurology; 1999 Sep; 53(5):1141-3. PubMed ID: 10496285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: a Singapore experience.
    Ty AU; See SJ; Rao JP; Khoo JB; Wong MC
    Neurology; 2006 Jan; 66(2):247-9. PubMed ID: 16434664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
    Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive oligodendroglioma: a chemosensitive tumor.
    Cairncross JG; Macdonald DR; Ramsay DA
    Neurosurgery; 1992 Jul; 31(1):78-82. PubMed ID: 1641113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade oligodendroglioma responds to chemotherapy.
    Mason WP; Krol GS; DeAngelis LM
    Neurology; 1996 Jan; 46(1):203-7. PubMed ID: 8559376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.
    Glass J; Hochberg FH; Gruber ML; Louis DN; Smith D; Rattner B
    J Neurosurg; 1992 May; 76(5):741-5. PubMed ID: 1564535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial chemotherapy in gliomatosis cerebri.
    Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
    Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
    Buckner JC; Gesme D; O'Fallon JR; Hammack JE; Stafford S; Brown PD; Hawkins R; Scheithauer BW; Erickson BJ; Levitt R; Shaw EG; Jenkins R
    J Clin Oncol; 2003 Jan; 21(2):251-5. PubMed ID: 12525516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
    Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships Between Dose Intensity, Toxicity, and Outcome in Patients with Oligodendroglial Tumors Treated with the PCV Regimen.
    Tabouret E; Reyes-Botero G; Dehais C; Daros M; Barrie M; Matta M; Petrirena G; Autran D; Duran A; Bequet C; Delattre JY; Chinot O
    Anticancer Res; 2015 May; 35(5):2901-8. PubMed ID: 25964574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
    Bouffet E; Mornex F; Jouvet A; Thiesse P; Mertens P; Helfre S; Sindou M; Bret P
    Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCV chemotherapy for oligodendroglioma: response analyzed on T2 weighted-MRI.
    Diabira S; Rousselet MC; Gamelin E; Soulier P; Jadaud E; Menei P
    J Neurooncol; 2001 Oct; 55(1):45-50. PubMed ID: 11804282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for the treatment of oligodendroglial tumors.
    Chinot O
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):13-8. PubMed ID: 11550134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.
    Brandes AA; Tosoni A; Vastola F; Pasetto LM; Coria B; Danieli D; Iuzzolino P; Gardiman M; Talacchi A; Ermani M
    Cancer; 2004 Nov; 101(9):2079-85. PubMed ID: 15372474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.